Concepedia

FcγRIIIa polymorphisms and cetuximab induced cytotoxicity in squamous cell carcinoma of the head and neck

Rodney J. Taylor, Siaw‐Lin Chan, Aaron Wood, Caroline Voskens, Jeffrey S. Wolf, Wei Lin, Andrei I. Chapoval, Dan H. Schulze, Guo‐Liang Tian, Scott E. Strome

Cancer Immunology Immunotherapy · 2008 · 101 citations · 26 references

DOIFull text

Open access

Concepts

References

26

Cancer Statistics, 2005

Ahmedin Jemal, Thomas S. Murray, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2005 · 5.5K citations · Full text

, , +16

Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

David Cunningham, Yves Humblet, Salvatore Siena et al. · New England Journal of Medicine · 2004 · 5K citations · Full text

, , +17

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene

Guillaume Cartron, Laurent Dacheux, Gilles Salles et al. · Blood · 2002 · 1.9K citations · Full text

, , +16

Two Immunoglobulin G Fragment C Receptor Polymorphisms Independently Predict Response to Rituximab in Patients With Follicular Lymphoma

Wen‐Kai Weng, Ronald Levy · Journal of Clinical Oncology · 2003 · 1.3K citations

, , +13

Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.

K. Kian Ang, Brian Berkey, Xiaoyu Tu et al. · PubMed · 2002 · 1.2K citations

, , +13